MimiVax Inc.

Private

Buffalo, New YorkHealthcare & Life Scienceshttps://www.mimivax.com/

Last Round

Debt

Jul 16, 2024

Total Funding Raised

$10M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MimiVax Inc. is a biotechnology company that develops immunotherapeutic vaccines and targeted therapies designed to control tumor growth and recurrence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

cancer vaccineSurVaxMimmunotherapypeptide vaccineglioblastomasurvivin targetbiopharma licensingclinical stage biotechmultiple myelomaneuroendocrine tumorsdrug developmentpediatric brain tumors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MimiVax Inc. Comps

Public and private peers based on sector, stage, and business model.

MimiVax Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MimiVax Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jul 16, 2024
VC Round	Jan 9, 2024
Corporate Funding	Nov 18, 2019
Grant	Jan 1, 2013

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Ciesielski

President & CEO

Executive Team

MimiVax Inc. Investors

Notable investors and investment history

MimiVax Inc. investors
Investor	Rounds
MEDA Angels	VC Round
Varia Ventures	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 21, 2026
Monthly visitors increased 39% MoM.
May 16, 2026
Monthly visitors increased 270% MoM.

View all signals

MimiVax Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

MimiVax Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MimiVax Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBuffalo, New York

Employee Range3

Year Founded2012

Last FundingJul 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.